Scott A. Ely
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 54
- Multiple Myeloma Research and Treatments 53
- Oncology 46
- Cancer Treatment and Pharmacology 11
- Cancer-related Molecular Pathways 10
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Selina Chen‐Kiang (47 shared papers)Rubén Niesvizky (49 shared papers)Daniel M. Knowles (9 shared papers)Ethel Cesarman (7 shared papers)John Paul Leonard (21 shared papers)Morton Coleman (37 shared papers)Ornella Flore (2 shared papers)Amy Chadburn (9 shared papers)
- Journals
- Blood (40 papers)British Journal of Haematology (5 papers)npj Breast Cancer (4 papers)Clinical Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Scott A. Ely
98 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 110
- Hematology 1.1k
- Oncology 2.3k
- Genetics 859
- Pathology and Forensic Medicine 1.3k
- Immunology 832
Countries citing papers authored by Scott A. Ely
This map shows the geographic impact of Scott A. Ely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Ely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Ely more than expected).
Fields of papers citing papers by Scott A. Ely
This network shows the impact of papers produced by Scott A. Ely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Ely. The network helps show where Scott A. Ely may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott A. Ely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 360 | |
| 2 | 2009 | 277 | |
| 3 | 2010 | 265 | |
| 4 | 2012 | 257 | |
| 5 | 2014 | 242 | |
| 6 | 2003 | 210 | |
| 7 | 2021 | 193 | |
| 8 | 2006 | 187 | |
| 9 | 2020 | 164 | |
| 10 | 2005 | 160 | |
| 11 | 2020 | 156 | |
| 12 | 2007 | 155 | |
| 13 | 2004 | 139 | |
| 14 | 2002 | 135 | |
| 15 | 2004 | 130 | |
| 16 | 2020 | 126 | |
| 17 | 2010 | 124 | |
| 18 | 2005 | 98 | |
| 19 | 2000 | 93 | |
| 20 | 2002 | 92 |
About Scott A. Ely
Scott A. Ely is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 103 papers that have together received 5.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (53 papers), Protein Degradation and Inhibitors (22 papers), Lymphoma Diagnosis and Treatment (17 papers), Cancer Treatment and Pharmacology (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Cancer-related Molecular Pathways (10 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (2.3k citations), Genetics (859 citations), Pathology and Forensic Medicine (1.3k citations) and Immunology (832 citations). Scott A. Ely has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Selina Chen‐Kiang, Rubén Niesvizky, Daniel M. Knowles, Ethel Cesarman, John Paul Leonard, Morton Coleman, Ornella Flore, Amy Chadburn, Peter Martin and Richard R. Furman. Their work appears in journals such as Blood, British Journal of Haematology, npj Breast Cancer, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.